Literature DB >> 18512138

A non-radioactive PCR-SSCP analysis allows to distinguish between HPV 16 European and Asian-American variants in squamous cell carcinomas of the uterine cervix in Colombia.

Pablo Moreno-Acosta1, Mónica Molano, Antonio Huertas, Myriam Sánchez de Gómez, Alfredo Romero, Mauricio González, María Mercedes Bravo, Alejandro García-Carrancá.   

Abstract

UNLABELLED: Human Papillomavirus type 16 (HPV 16) DNA is regularly found in around 50% of all cervical carcinomas. Variants of this type have been found associated with different risks for cervical cancer development. Presence of HPV 16 variants in Colombia has not been previously reported. The aims of this study were to assess the feasibility of non-radioactive PCR-SSCP (polymerase chain reaction single-strand conformation polymorphism) analysis for determination of variability of ORF of E6, variability in the enhancer sequence of the LCR, and for establishment of the distribution of HPV 16 variants in invasive squamous cell carcinoma of the uterine cervix in Colombian women. Biopsies from 59 patients at the Instituto Nacional de Cancerología (INC) in Bogotá (Colombia) were collected. HPV detection was performed using universal primers. HPV 16 variants were detected by non-radioactive single-stranded conformational polymorphism (SSCP) analysis and direct sequencing. HPV 16 was detected in 57.6% of the tumors. The European branch was identified in 88.2% of the samples with the E-G350 class being the most prevalent variant (41.1%). The Asian-American branch was identified in 8.8% of the samples. Within this group it was possible to distinguish between c and a classes. It was not possible to determine the branch in 2.9% of the cases. A nucleotide transition (G to A) at position 7521 was the most prevalent variation (80%) found in the enhancer sequence of the LCR region.
CONCLUSION: A non-radioactive PCR-SSCP analysis allowed us to distinguish between European and Asian-American branches of HPV 16, and to distinguish among classes in squamous cell carcinomas of the uterine cervix in Colombia. This method is an excellent alternative that can be used as a screening tool for identification of HPV 16 variants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18512138     DOI: 10.1007/s11262-008-0239-8

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  42 in total

1.  Estimating the world cancer burden: Globocan 2000.

Authors:  D M Parkin; F Bray; J Ferlay; P Pisani
Journal:  Int J Cancer       Date:  2001-10-15       Impact factor: 7.396

2.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.

Authors:  T Yamada; M M Manos; J Peto; C E Greer; N Munoz; F X Bosch; C M Wheeler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Mutational and functional analysis of HPV-16 URR derived from Korean cervical neoplasia.

Authors:  J S Park; E S Hwang; C J Lee; C J Kim; J G Rha; S J Kim; S E Namkoong; S J Um
Journal:  Gynecol Oncol       Date:  1999-07       Impact factor: 5.482

4.  Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study.

Authors:  J Berumen; R M Ordoñez; E Lazcano; J Salmeron; S C Galvan; R A Estrada; E Yunes; A Garcia-Carranca; G Gonzalez-Lira; A Madrigal-de la Campa
Journal:  J Natl Cancer Inst       Date:  2001-09-05       Impact factor: 13.506

5.  Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results.

Authors:  Nubia Muñoz; Fabián Méndez; Héctor Posso; Mónica Molano; Adrian J C van den Brule; Margarita Ronderos; Chris Meijer; Alvaro Muñoz
Journal:  J Infect Dis       Date:  2004-11-22       Impact factor: 5.226

6.  High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18.

Authors:  Laura Sichero; Silvaneide Ferreira; Helen Trottier; Eliane Duarte-Franco; Alex Ferenczy; Eduardo Luis Franco; Luisa Lina Villa
Journal:  Int J Cancer       Date:  2007-04-15       Impact factor: 7.396

Review 7.  The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses.

Authors:  Hans-Ulrich Bernard
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

8.  Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.

Authors:  Ingeborg Zehbe; Joannis Mytilineos; Ingrid Wikström; Rudi Henriksen; Lutz Edler; Massimo Tommasino
Journal:  Hum Immunol       Date:  2003-05       Impact factor: 2.850

9.  Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers.

Authors:  X P Dong; F Stubenrauch; E Beyer-Finkler; H Pfister
Journal:  Int J Cancer       Date:  1994-09-15       Impact factor: 7.396

10.  The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations.

Authors:  L Ho; S Y Chan; R D Burk; B C Das; K Fujinaga; J P Icenogle; T Kahn; N Kiviat; W Lancaster; P Mavromara-Nazos
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

View more
  2 in total

1.  Biomarkers of resistance to radiation therapy: a prospective study in cervical carcinoma.

Authors:  P Moreno-Acosta; A Vallard; S Carrillo; O Gamboa; A Romero-Rojas; M Molano; J Acosta; D Mayorga; C Rancoule; M A Garcia; M Cotes Mestre; N Magné
Journal:  Radiat Oncol       Date:  2017-07-17       Impact factor: 3.481

2.  Persistent High-Risk HPV Infection and Molecular Changes Related to the Development of Cervical Cancer.

Authors:  Pablo Moreno-Acosta; Alfredo Romero-Rojas; Nicolas Vial; Antonio Huertas; Jinneth Acosta; Diana Mayorga; Schyrly Carrillo; Monica Molano; Oscar Gamboa; Martha Cotes; Camila Casadiego; Alexis Vallard; Nicolas Magne
Journal:  Case Rep Obstet Gynecol       Date:  2020-07-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.